The BioStar OIA CdTOX AB assay is an immunoassay test for the rapid qualitative detection of Clostridium difficile Toxins A and/or B in human faecal samples from patients suspected of having CDAD. Toxin A is an enterotoxin which appears to be responsible for the clinical symptoms of diarrhoea and colonic inflammation, while Toxin B is responsible for the associated cell destruction. Clinical symptoms of CDAD were once thought to be solely due to Toxin A; however, there is growing evidence that Toxin B may also play an important role in the pathogenesis of C. difficile. In many markets it is mandatory to use a test that detects both toxins, therefore a test which detects both toxins would be an aid to prompt diagnosis and allow the physician to initiate appropriate patient management.
The BioStar OIA CdTOX AB assay provides obvious benefits when it comes to time to result. A positive or negative result can be achieved in just 10 mins, which is a significant advantage when compared to Enzyme Immunoassay (EIA) (which can take 2-4 h) and Cytotoxicity methods (which can take 24-48 h) to yield a result.
The BioStar OIA enteric product range also offers a unique rapid assay for the qualitative detection of Shiga toxins in faecal samples; the product allows fast and accurate diagnosis of infection by Shiga Toxin-producing bacteria.
Phone: 0011 643 548 4727
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...